Deflazacort Oral Suspension
NDC 57664-993, Deflazacort Oral, suspension, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 57664-993
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219930
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57664-993 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFLAZACORT22.75 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57664-993-01 | 57664099301 | 13 mL in 1 BOTTLE (57664-993-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2fac1332-0247-1047-e063-6294a90a557f
Use it
Look up 57664-993 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57664-993 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57664-993. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.